AMPLIMUNE
Novavive Inc.
Trademark Registered: 2018-01-23
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86613515 |
| Registration Number | 5383140 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Stephen R. Barrese |
| Attorney Docket Number | 1481-32 |
| Law Office Assigned | M60 |
| Employee Name | BRODY, DANIEL S |
Timeline
| 2015-04-29 | Application Filed |
| 2017-11-07 | Published for Opposition |
| 2018-01-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-01-23 | Status: Live/Registered |
| 2018-01-23 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novavive Inc. |
| Address | 79 Howard Cres. PO Box 3005, RR#7 Belleville, Ontari CA K8N4Z7 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | An immunotherapeutic agent for the treatment of ruminants, namely, for the treatment of neonatal and juvenile diseases; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea in neonates |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-05-11 | 1 NWOS I:Incoming Correspondence |
| NOTICE OF PSEUDO MARK E-MAILED | 2015-05-12 | 2 MPMK E:E-Mail |
| ASSIGNED TO EXAMINER | 2015-08-10 | 3 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2015-08-12 | 4 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2015-08-12 | 5 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2015-08-12 | 6 GNS3 O:Outgoing Correspondence |
| SUSPENSION INQUIRY WRITTEN | 2016-02-12 | 7 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2016-02-12 | 8 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2016-02-12 | 9 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2016-08-03 | 10 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2016-08-12 | 11 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-08-15 | 12 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-08-15 | 13 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2016-08-19 | 14 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2016-08-19 | 15 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-08-19 | 16 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2016-11-15 | 17 DOCK D:Assigned to Examiner |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2017-02-24 | 18 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2017-02-26 | 19 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2017-02-26 | 20 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2017-02-26 | 21 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2017-08-17 | 22 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-08-23 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-08-23 | 24 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2017-08-28 | 25 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2017-08-28 | 26 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2017-08-28 | 27 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2017-09-20 | 28 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-10-02 | 29 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-10-02 | 30 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-10-02 | 31 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-10-03 | 32 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-10-18 | 33 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-11-07 | 34 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-11-07 | 35 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2018-01-23 | 36 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-01-23 | 37 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2024-01-11 | 38 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2024-07-25 | 39 APRE A:Allowance for Publication |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AMPLIMUNE 86613515 5383140 Live/Registered |
Novavive Inc. 2015-04-29 |
 AMPLIMUNE 74151598 1841147 Dead/Cancelled |
BIONICHE LIFE SCIENCES INC. 1991-03-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 